Apc2 - APC regulator of WNT signaling pathway 2 Gene
Also Known as APCL
Species: Mus musculus
Summary
Predicted to enable beta-catenin binding activity; gamma-catenin binding activity; and microtubule binding activity. Predicted to be involved in several processes, including activation of GTPase activity; negative regulation of canonical Wnt signaling pathway; and negative regulation of microtubule depolymerization. Predicted to be located in several cellular components, including cytoskeleton; lamellipodium membrane; and midbody. Predicted to be part of beta-catenin destruction complex; catenin complex; and filamentous actin. Predicted to colocalize with cytoplasmic microtubule. Is expressed in several structures, including appendicular skeleton; axial skeleton; nervous system; and sensory organ. Human ortholog(s) of this gene implicated in Sotos syndrome 3 and complex cortical dysplasia with Other brain malformations. Orthologous to human APC2 (APC regulator of Wnt signaling pathway 2). [provided by Alliance of Genome Resources, Apr 2022]
Apc2 Products (6)
| mRNA | Protein | Name |
|---|---|---|
| NM_001372237.1 | NP_001359166.1 | adenomatous polyposis coli protein 2 isoform 2 precursor |
| NM_001372238.1 | NP_001359167.1 | adenomatous polyposis coli protein 2 isoform 3 precursor |
| NM_001372239.1 | NP_001359168.1 | adenomatous polyposis coli protein 2 isoform 4 |
| NM_001372240.1 | NP_001359169.1 | adenomatous polyposis coli protein 2 isoform 1 |
| NM_001372241.1 | NP_001359170.1 | adenomatous polyposis coli protein 2 isoform 6 |
| NM_011789.2 | NP_035919.2 | adenomatous polyposis coli protein 2 isoform 5 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
adenomatous polyposis coli protein 2 |
|